Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
HDA Survey Results Indicate More Preparation Necessary for Connecting EPCIS-Enabled Systems Before DSCSA Deadline
Data released by the Healthcare Distribution Alliance (HDA) indicate more preparation is needed to ensure all healthcare supply chain partners are ready to meet the requirements of the Drug Supply Chain Security Act (DSCSA). HDA’s latest EPCIS Implementation Benchmarking Survey provides a final report on supply chain partners’ progress toward the November 27, 2023, deadline to connect data systems to exchange serialized transaction data for all pharmaceuticals.
A Conversation About Pharmaceutical Supply Chain Resilience and COVID-19
On October 27, HDA and The Hill brought together policymakers, leaders in the pharmaceutical industry and public health experts to discuss the supply chain’s response during COVID-19. In conversation with Steve Clemons, Editor-in-Chief of The Hill, speakers provided key insights on ensuring the strength and resilience of the pharmaceutical supply chain during this unprecedented crisis. Below are five takeaways from the dialogue.
HDA Shares Insights on Supply Chain Resilience and Drug Shortages at Duke-Margolis Conference
HDA President and CEO, Chip Davis, recently participated on a panel at the 2025 Duke Margolis Health Policy Conference.
Latest Faces of the Supply Chain Videos Underscore Industry’s Focus on Safety and Reliability
HDA’s Faces of the Supply Chain series continued this past month with the release of new videos featuring perspectives from nine distribution sector experts. Interviews touched upon topics ranging from innovations in healthcare distribution and manufacturing; the industry’s focus on patients; supply chain resilience through the COVID-19 pandemic; and more.